Clinical Trial Update: Randomized Phase II Trial Evaluating DFS in The Absence of an Adjuvant Component of Perioperative Chemotherapy in Patients With Gastric Cancer [Phase 2]

View source ↗

Summary

A randomized Phase II trial in gastric cancer evaluates disease-free survival when the adjuvant component of perioperative chemotherapy is omitted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: Nizhny Novgorod Regional Clinical Oncology Center | Conditions: Gastric Cancer | Phase 2 | Status: NOT_YET_RECRUITING